drugset / Trial / NCT00622362
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this trial is to evaluate the clinical effectiveness of the administration of a depigmented and polymerized allergen extract Dermatophagoides pteronyssinus in children with allergic asthma due to this mite
Timeline
- Start
- 2008-01
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Depigoid | Other / unclassified | 0.5 ml | Subcutaneous |
| Subject | TOL | Unknown | — | Other |